A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)

Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
08/2011
08/24/2011	CN101372514B Scaphium scaphigerum polysaccharide, preparation and use thereof
08/24/2011	CN101111521B Humanized antibody specific for tumor necrosis factor-alpha
08/24/2011	CN101102751B Reverse micelle composition for delivery of metal cations comprising a diglyceride and a phytosterol and method of preparation
08/24/2011	CN101081834B Process for the preparation of leukotriene antagonists
08/23/2011	US8003805 N3 alkylated benzimidazole derivatives as MEK inhibitors
08/23/2011	US8003791 Boronic ester and acid compounds, synthesis and uses
08/23/2011	US8003772 Chimeric PUFA polyketide synthase systems and uses thereof
08/23/2011	US8003701 Method of inhibiting inflammatory pain
08/23/2011	US8003651 Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
08/23/2011	US8003615 Stable vitamin B6 derivative
08/23/2011	US8003608 Using small molecule amino acid derivatives
08/23/2011	US8003347 Nucleic acids encoding ChemerinR ligands
08/23/2011	US8003109 Pharmaceutical compositions containing the long pentraxin PTX3
08/23/2011	US8003101 Inflammatory mediator antagonists
08/23/2011	CA2504820C Pyrazolonaphthyridine derivatives
08/23/2011	CA2483162C Use of 3-substituted amino-1h-indole-2-carboxylic acid and 3-substituted amino benzo[b]thiophene-2-carboxylic acid derivatives as il-4 inhibitors
08/23/2011	CA2478186C Fluorinated 4-azasteroid derivatives as androgen receptor modulators
08/23/2011	CA2458632C Urea-compounds active as vanilloid receptor antagonists for the treatment of pain
08/23/2011	CA2442159C Treatment using neublastin polypeptides
08/23/2011	CA2377209C Therapeutic peptide-based constructs
08/23/2011	CA2368218C Oat extracts: refining, compositions and methods of use
08/23/2011	CA2270176C Methylated, smd homologous peptides, reactive with the antibodies from sera of living beings affected with systemic lupus erythematosus
08/18/2011	WO2011100359A1 Cannabinoid agonists
08/18/2011	WO2011100324A1 Cannabinoid receptor agonists
08/18/2011	WO2011100227A1 Benzylpyrrolidinone derivatives as modulators of chemokine receptor activity
08/18/2011	WO2011099832A2 Novel benzimidazole compound, preparation method thereof and pharmaceutical composition comprising the same
08/18/2011	WO2011099576A1 Aptamer to fgf2 and use thereof
08/18/2011	WO2011098801A1 Inflammatory disease treatment
08/18/2011	WO2011098452A1 6-amino-2-{ [ (1s)-1-methylbutyl] oxy}-9-[5-(1-piperidinyl)-7,9-dihydro-8h-purin-8-one maleate
08/18/2011	WO2011098451A1 Purine derivatives and their pharmaceutical uses
08/18/2011	WO2011098035A1 Sinomenine derivatives, synthetic methods and uses thereof
08/18/2011	WO2011097797A1 Polyphenol acrylic acid derivative, preparation and use in preparing medicine thereof
08/18/2011	WO2011097750A1 Compositions, products, therapeutic uses and procedures for the production and/or crystallisation of extracts of encelia canescens lam (coronilla de fraile)
08/18/2011	WO2011097691A1 Composition containing resveratrol and/or derivatives thereof and plant oil, process for producing said composition, nutraceutical and/or pharmaceutical product, and method for enhancing the potential of resveratrol
08/18/2011	WO2011049810A3 Compositions and methods for treating inflammation and fibrosis
08/18/2011	WO2011047055A3 Novel mek inhibitors, useful in the treatment of diseases
08/18/2011	WO2010151797A3 Compounds for modulating rna binding proteins and uses therefor
08/18/2011	US20110201685 Compositions
08/18/2011	US20110201676 Method of treating inflammatory arthropathies with suppressors of cpg oligonucleotides
08/18/2011	US20110201663 Benzo (f) isoindol-2-ylphenyl acetic acid derivatives as ep4 receptor agonists
08/18/2011	US20110201657 Amide substituted indazole and benzotriazole derivatives as poly(adp-ribose)polymerase (parp) inhibitors
08/18/2011	US20110201656 Novel diphenyl 1,2,3-triazole derivatives useful as modulators of nicotinic acetylcholine receptors
08/18/2011	US20110201651 Mitotic kinesin inhibitors and methods of use thereof
08/18/2011	US20110201647 [4-(5-aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-[7-fluoro-1-(2-methoxy-ethyl)-4-trifluoromethoxy-1h-indol-3-yl]-methanone as an inhibitor of mast cell tryptase
08/18/2011	US20110201643 Novel n-substituted tetrahydroisoquinoline/isoindoline hydroxamic acid compounds
08/18/2011	US20110201641 Indole derivatives as crth2 receptor antagonists
08/18/2011	US20110201638 PHENANTHROINDOLIZIDINE COMPOUND AND NFkB INHIBITOR CONTAINING SAME AS ACTIVE INGREDIENT
08/18/2011	US20110201629 Cyclohexyl amide derivatives as crf receptor antagonists
08/18/2011	US20110201625 Organic Comopunds
08/18/2011	US20110201611 Process for the Preparation of Compositions for Modulating a Kinase Cascade and Methods of Use Thereof
08/18/2011	US20110201610 Aryl sulfonamides
08/18/2011	US20110201606 Pyrimidine derivatives
08/18/2011	US20110201604 Substituted Fused Imidazole Derivatives, Pharmaceutical Compositions, and Methods of Use Thereof
08/18/2011	US20110201601 Inhibitors of the shiga toxins trafficking through the retrograde pathway
08/18/2011	US20110201589 New bradykinin b1 antagonists
08/18/2011	US20110201574 Fatty acid amide hydrolase inhibitors
08/18/2011	US20110201570 Nucleus pulposus filler
08/18/2011	US20110201559 New Optically Pure Compounds for Improved Therapeutic Efficiency
08/18/2011	US20110201555 Novel estrogen receptor ligands
08/18/2011	US20110201540 Glycosylation of Molecules
08/18/2011	US20110201029 Il-13 receptor antibodies
08/18/2011	US20110200990 RECEPTOR ACTIVATOR OF NF kappa-B
08/18/2011	US20110200694 Promotors of Ceramide's Generation
08/18/2011	US20110200677 Prostate specific membrane antigen (psma) targeted nanoparticles for therapy of prostate cancer
08/18/2011	US20110200657 Methods of using nanoemulsion compositions having anti-inflammatory activity
08/18/2011	US20110200642 Compositions and Methods to Promote Implantation and Engrafment of Stem Cells
08/18/2011	US20110200617 Combination therapy of beta-glycolipids and antibodies for the treatment of immune-related disorders
08/18/2011	US20110200611 Plasma kallikrein binding proteins
08/18/2011	US20110200609 Monoclonal antibodies specific for pathological amyloid aggregates common to amyloids formed from proteins of differing sequence
08/18/2011	US20110200605 Polypeptides and use thereof
08/18/2011	US20110200600 Diagnosis and prognosis of immune disorders using stat4 expression
08/18/2011	US20110200587 Aminothiazolones as estrogen related receptor-alpha modulators
08/18/2011	US20110200586 Aminothiazolones as estrogen related receptor-alpha modulators
08/18/2011	US20110200585 Cd127 binding proteins
08/18/2011	US20110200541 Recombinant preparation of bromelain inhibitors and bromelain inhibitor precursor
08/18/2011	DE102010008468A1 Extract of a fruit body derivative of Antrodia cinnamomea, useful for treating inflammation, obtained by providing a dried fruit body of Antrodia cinnamomea, and extracting with ethanol to obtain acetic acid extract
08/18/2011	CA2788400A1 Antibodies against cxcr4
08/18/2011	CA2786973A1 6-amino-2-{ [ (1s)-1-methylbutyl] oxy}-9-[5-(1-piperidinyl)-7,9-dihydro-8h-purin-8-one maleate
08/17/2011	EP2357200A1 Human antibodies that bind human TNFalpha
08/17/2011	EP2357193A1 Human GIL-19/AE289 proteins and polynucleotides encoding same
08/17/2011	EP2357009A1 Duramycin peptide binding to anionic phospholipids and aminophospholipids conjugates and their use in treating viral infections
08/17/2011	EP2357008A1 Albumin fusion proteins
08/17/2011	EP2357002A1 Nucleic acid molecules and polypeptides for immune modulation
08/17/2011	EP2356994A2 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases
08/17/2011	EP2356987A1 Methods for purifying trans-(-)-delta9-tetrahydrocannabinol and trans-(+)-delta9-tetrahydrocannabinol
08/17/2011	EP2356111A1 Compounds for the treatment of inflammatory disorders
08/17/2011	EP2356108A1 Carbamate derivatives of alkyl-heterocycles, preparation thereof and therapeutic use thereof
08/17/2011	EP2356093A1 Carbazole compounds and therapeutic uses of the compounds
08/17/2011	EP2355903A1 Product and composition for alleviating post-menstrual symptoms comprising carapa procera and calotropis procera
08/17/2011	EP2355814A2 Pyrones for the treatment of metabolic disorders
08/17/2011	EP2355807A1 Inhibitors of dimethylarginine dimethylaminohydrolase
08/17/2011	EP2355657A1 Compositions and methods of treating endothelial disorders
08/17/2011	EP2225231B1 Aminotriazole derivatives as alx agonists
08/17/2011	EP2222631B1 Substituted phenylmethyl bicyclocarboxyamide compounds
08/17/2011	EP2127668B1 Glycosyltransferase for treating Inflammatory Bowel Disease
08/17/2011	EP1781619B1 Sigma receptor inhibitors
08/17/2011	EP1558273B1 Treatment and prevention of pulmonary conditions
08/17/2011	EP1456419B1 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby
08/17/2011	EP1379507B1 HETEROARYL UREAS CONTAINING NITROGEN HETERO-ATOMS AS p38 KINASE INHIBITORS
08/17/2011	EP1246808B1 1,2-diaryl benzimidazoles for treating illnesses associated with a microglia activation

1 ... 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 ... 1272